L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea · Delayed Price · Currency is KRW 53,300
+1,500 (2.90%)
Aug 20, 2026, 3:30 PM KST
L&C BIO Co.,LTD Market Cap
L&C BIO Co.,LTD has a market cap or net worth of 1.4 trillion as of August 20, 2026. Its market cap has increased by 83.65% in one year.
Market Cap
1.40T
Enterprise Value
1.45T
Revenue
98.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
53,300.00
ChartMarket Cap Chart
Since November 1, 2018, L&C BIO Co.,LTD's market cap has increased from 194.97B to 1.40T, an increase of 616.55%. That is a compound annual growth rate of 28.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 1.44T | -4.44% |
| Dec 30, 2025 | 1.50T | 175.14% |
| Dec 30, 2024 | 546.71B | -16.90% |
| Dec 28, 2023 | 657.86B | 25.54% |
| Dec 29, 2022 | 524.02B | -36.89% |
| Dec 30, 2021 | 830.27B | 10.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CLASSYS | 2.26T |
| SD Biosensor | 735.66B |
| BioNote | 496.85B |
| T&L Co., Ltd. | 493.05B |
| Samyang Biopharm | 337.96B |
| Vieworks | 242.67B |
| Dongbang Medical | 131.67B |
| Shinhung | 129.09B |